நரம்பியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நரம்பியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நரம்பியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி Today - Breaking & Trending Today

Doctors advise against off-label use of new Alzheimer's medicine for cerebral amyloid angiopathy


Doctors advise against off-label use of new Alzheimer s medicine for cerebral amyloid angiopathy
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer s disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
In a letter published in
The Lancet Neurology, Greenberg and eight other officers of the association wrote that there is no clinical evidence that the monoclonal antibody aducanumab is beneficial to patients with CAA, a condition in which proteins known as amyloid corrode arterial walls in the brain and can lead to bleeding and stroke. ....

United States , Steven Greenberg , Emily Henderson , Hemorrhagic Stroke Research Program At Massachusetts , Neurology At Harvard Medical School , Hemorrhagic Stroke Research Program , Drug Administration , International Cerebral Amyloid Angiopathy Association , Massachusetts General Hospital , Lancet Neurology , Harvard Medical School , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீவன் க்ரீன்பெர்க் , எமிலி ஹென்டர்சன் , நரம்பியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி , மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை , ஹார்வர்ட் மருத்துவ பள்ளி ,

Technology to predict strokes - INDIA New England News


INDIA New England News
The Harvard Gazette 
For patients who have experienced certain common types of stroke, a small chip inserted under the skin may help physicians predict their likelihood of experiencing a second stroke, and therefore their likelihood of benefiting from preventive therapy. The findings come from a recent clinical trial published in the Journal of the American Medical Association and led by investigators at Harvard-affiliated Massachusetts General Hospital (MGH) and Northwestern University Feinberg School of Medicine.
Each year, approximately 800,000 strokes occur in the United States, and as many as one-fourth occur in people who experienced a previous stroke. Investigators have been searching for ways to identify patients who are likely to experience a recurrent stroke, as these individuals could be candidates for taking certain medications such as blood thinners. One group of patients who face an elevated risk of recurrent strokes a ....

New York , United States , North Carolina , Duke University Medical Center , Richarda Bernstein , Jonathanp Piccini , C Miller Fisher , Pramodp Sethi , Tracy Hampton , Hooman Kamel , Leeh Schwamm , Norelic Franco , Jeffreym Katz , Carola Alfaro Vives , Pauld Ziegler , Christopherb Granger , Neurology At Harvard Medical School , Shore University Hospital In Manhasset , Northwestern University Feinberg School Of Medicine , Journal Of The American Medical Association , Guilford Neurologic Research Associates In Greensboro , Cone Health Stroke Center , Harvard Gazette , American Medical Association , Harvard Affiliated Massachusetts General Hospital , Northwestern University Feinberg School ,